This inventor holds 1 USPTO granted patent. Top assignee: Axxima Pharmaceuticals Ag. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: The Innovations of Daniel Schubart
Introduction
Daniel Schubart is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of virology, particularly in understanding the mechanisms of Human Cytomegalovirus (HCMV) infection. His work focuses on cellular kinases and their role in HCMV, which has implications for therapeutic development.
Latest Patents
One of Schubart's key patents is titled "Cellular kinases involved in Cytomegalovirus infection and their inhibition." This patent discloses the role of certain cellular kinases that are active during HCMV infection. These kinases are not only useful for detecting HCMV infection but also serve as targets for screening cellular kinase inhibitors. The inhibitors that effectively downregulate these key cellular components can be developed as therapeutics against HCMV infection. Schubart holds 1 patent in this area.
Career Highlights
Daniel Schubart is associated with Axxima Pharmaceuticals AG, where he continues to advance research in the field of virology. His work has been instrumental in paving the way for new therapeutic strategies against viral infections.
Collaborations
Throughout his career, Schubart has collaborated with notable colleagues, including Peter Habenberger and Dorian Bevec. These collaborations have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Daniel Schubart's innovative work in the realm of cellular kinases and HCMV infection highlights the importance of targeted therapies in virology. His contributions are paving the way for future advancements in the treatment of viral infections.